The Exchange had sought clarification from Laurus Labs Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NSE sought clarification from Laurus Labs regarding three deficiencies in the Q2 FY26 (quarter ended September 30, 2025) financial results filing under Regulation 33 of SEBI LODR. The company explained that: (1) the machine-readable PDF was not submitted due to a temporary technical issue on the NEAPS portal, (2) the results were not uploaded within the prescribed time limit due to a technical glitch, and (3) the XBRL filing contained discrepancies because half-yearly figures were inadvertently selected. All issues were attributed to technical problems rather than intent, and the corrected XBRL was filed. Meanwhile, Q2 standalone revenue grew 32% year-on-year to Rs 1,566.60 crores with net profit at Rs 215.67 crores, while consolidated revenue reached Rs 1,653.47 crores. The company also declared an interim dividend of Rs 0.80 per share.
These were administrative and technical filing errors rather than financial or operational issues. The company has clarified and corrected the XBRL filing. The underlying Q2 results showed strong year-on-year growth in both revenue and profits, indicating no fundamental concern for shareholders.